Markers of tumor-initiating cells predict chemoresistance in breast cancer.
<h4>Purpose</h4>Evidence is lacking whether the number of breast tumor-initiating cells (BT-ICs) directly correlates with the sensitivity of breast tumors to chemotherapy. Here, we evaluated the association between proportion of BT-ICs and chemoresistance of the tumors.<h4>Methods&...
Guardado en:
Autores principales: | Chang Gong, Herui Yao, Qiang Liu, Jingqi Chen, Junwei Shi, Fengxi Su, Erwei Song |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17ee16d5b0d44ad0bb3a478aeac58cea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
por: Qingjian Li, et al.
Publicado: (2020) -
A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
por: Huiping Li, et al.
Publicado: (2018) -
MiR-27 as a prognostic marker for breast cancer progression and patient survival.
por: Wei Tang, et al.
Publicado: (2012) -
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
por: Yinghua Zhu, et al.
Publicado: (2018) -
The role of peroxiredoxin II in chemoresistance of breast cancer cells
por: Wang T, et al.
Publicado: (2014)